Touyun Biotech Group Limited has issued formal notice of its Annual General Meeting to be held at 10:30 a.m. on 5 June 2026 at The Harbourview, Wanchai, Hong Kong.

Key agenda items:

1. 2025 Results • Shareholders will receive the audited financial statements and directors’ and auditors’ reports for the year ended 31 December 2025.

2. Board Composition and Remuneration • Re-election of Executive Director Du Dong. • Re-election of Non-executive Directors Chen Hui and Zhang Lele. • Authorisation for the board to set directors’ remuneration.

3. Audit Arrangement • Proposal to re-appoint Moore CPA Limited as independent auditor with board-determined fees.

4. Capital Management Mandates • General issuance mandate: authority to allot and issue new shares or convertible securities up to 20% of issued share capital as at the AGM date, inclusive of any transfer of treasury shares. • Share repurchase mandate: authority to buy back up to 10% of issued shares (excluding treasury shares) within the mandate period. • Extension mandate: number of shares repurchased under the 10% mandate can be added to the 20% issuance limit.

5. Governance Update • Special resolution to adopt a second amended and restated set of bye-laws, consolidating proposed amendments detailed in the circular dated 22 April 2026.

Administrative details:

• The share register closes from 2 June 2026 to 5 June 2026 (both days inclusive). • Record date for AGM eligibility is 5 June 2026. • Proxy forms must be lodged with Tricor Investor Services Limited at Far East Finance Centre by 4:30 p.m. on 3 June 2026.

As of the notice date (22 April 2026), the board comprises Chairman Wang Liang, Executive Director Du Dong, three Non-executive Directors (Chen Hui, Tian Yuze and Zhang Lele) and three Independent Non-executive Directors (Cheung Wing Ping, Ha Kee Choy Eugene and To Shing Chuen).